RWE in an Evolving Regulatory Landscape: Using Real-World Evidence to Support Novel Product Development Pathways Webinar

October 1, 2019

RWE in an Evolving Regulatory Landscape: Using Real-World Evidence to Support Novel Product Development Pathways

Speakers:

Leanne Larson, Corporate Vice President and WW Head, Real-World Evidence, Parexel
Amy McKee, M.D., Vice President, Regulatory Consulting Services, Parexel

Tuesday - October 1, 2019 / 10:00am EDT
Free Event

The growing interest in RWE from both regulators and payors, along with innovative data models and technologies, has the potential to transform clinical research as we know it. Particularly for rare diseases, the opportunity to utilize existing data and to link patients across multiple datasets, in concert with proven prospective research models within non-traditional infrastructure settings, offers important opportunities both to streamline the research process and also to bring the needed real-world perspective and data to the table. Real-world data also can provide important information in the post-marketing setting, especially from a safety perspective, to answer regulatory questions. In this session, we will discuss:

  • The changing global regulatory perspective on RWE

  • Utilizing RWE in synthetic control arms to support regulatory submissions

  • Innovative approaches to accessing and integrating RWE today

EVENT WEBSITE

ADD TO CALENDAR

We are always available for a conversation.

*